---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-23-188158"
form_type: "8-K"
ticker: "ABOS"
cik: "0001576885"
company_name: "Acumen Pharmaceuticals, Inc."
filed_at: "2023-07-17T23:59:59+00:00"
generated_at: "2026-06-13T07:41:04.912825+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Acumen Pharmaceuticals files preliminary prospectus for common stock offering; reports $172.2M cash as of June 30, 2023

## Summary
- Company plans to offer shares of common stock; no terms disclosed.
- Preliminary cash and cash equivalents and marketable securities total $172.2M as of June 30, 2023.
- Financial results for Q2 2023 are preliminary and subject to completion; actual results may differ materially.

## SEC filing metadata
- accession: 0001193125-23-188158
- form_type: 8-K
- ticker: ABOS
- cik: 0001576885
- company_name: Acumen Pharmaceuticals, Inc.
- filed_at: 2023-07-17T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 2.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1576885/000119312523188158/0001193125-23-188158-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1576885/000119312523188158/d506616d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-23-188158
- JSON: https://secwatch.observer/filing/0001193125-23-188158.json
- Plain text: https://secwatch.observer/filing/0001193125-23-188158.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.